NCT03563040 2021-09-08PROMPTEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Withdrawn
NCT00093678 2015-10-08Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced CancerEastern Cooperative Oncology GroupPhase NA Withdrawn
NCT01386398 2015-01-21Vorinostat With or Without Bortezomib in Treating Patients With Refractory or Recurrent Stage IIB, Stage III, or Stage IV Cutaneous T-Cell LymphomaEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 3 Withdrawn